RXWell to Decrease Post-Operative Opioid Use in Total Knee or Hip Arthroplasty
Telemedicine-delivered Digital Cognitive Behavioral Intervention to Decrease Post-operative Opioid Use Among Patients Undergoing Total Knee or Hip Arthroplasty
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 18 Years to 100 Years
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study tests whether RxWell can help people use less opioid pain medicine after a total knee or hip replacement. It is for adults with moderately high anxiety or depression symptoms and focuses on managing mood before and after surgery.
It is envisioned that multipronged benefits from this pilot work for the UPMC ISD and its members. It is expected the RxWell platform to provide the following benefits: expansion of the use of RxWell to all UPMC ISD members providing peri-operative mood management with advantage of improved peri-operative outcomes, improving saving for the UPMC ISD by hastening the recovery and decreased resource utilization, and addition to the high-value care of UPMC with this holistic approach to patient perioperative care
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- You are older than 18.
- You are scheduled for a planned first total knee or hip replacement at an approved UPMC hospital.
- You score 60 or higher on the PROMIS anxiety or depression survey, which measures mood symptoms.
Who can't join
- Your surgery is not planned in advance, or it is a repeat joint replacement.
- You have current confusion, problems with memory or thinking, or a severe intellectual disability.
- You do not have access to a smartphone or tablet.
- You drink more than 1 liter of wine or 3 or more shots of hard liquor daily, or use illegal drugs daily.
- You have severe mood symptoms that need care right away, such as thoughts of suicide.
- You score above 70 on the PROMIS anxiety or depression survey. People who need care right away will be referred to mental health doctors and their main care team.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria for the RXWell Study: * Adults \>18 years * Scheduled for elective primary total knee arthroplasty (TKA) or hip replacement (THA) at the approved UPMC hospitals * Moderately high levels of mood disorder symptoms on validated PROMIS measures, defined as a T-score \> or = to 60 on PROMIS Anxiety 4a short form and/or PROMIS Depression4a short form Exclusion Criteria for the RXWell Study: * Patients undergoing non-elective surgery or secondary arthroplasty * Active delirium, neurocognitive impairment, or severe intellectual disability * No access to a smart device (phone or tablet) * Active alcoholism (defined as daily use of more than 1 liter of wine and /or 3 or more shots of hard liquor) or drug abuse (defined as daily use of illicit drugs) * Profound mood disorders requiring immediate intervention such as suicidal ideation, defined as a PROMIS Depression score of more than 70 * A PROMIS Anxiety and/or Depression T-score \>70, which corresponds to severe anxiety and depression. * Patients needing immediate care will be referred to psychiatrists and primary team.
Study sites (3)
PA
- UPMC East · Monroeville, PA 15146Ata Murat Kaynar, MD, MPH · Study contact · 412-383-3463 · kaynarm@upmc.eduAmy Monroe, MPH, MBA · Study contact · 4126236382 · monroeal@upmc.eduMore trials in Monroeville
- UPMC Shadyside · Pittsburgh, PA 15232Ata Murat Kaynar, MD, MPH · Study contact · 412-383-3463 · kaynarm@upmc.eduAmy Monroe, MPH, MBA · Study contact · 4126236382 · monroeal@upmc.eduMore trials in Pittsburgh
- UPMC Passavant · Pittsburgh, PA 15237Ata Murat Kaynar, MD, MPH · Study contact · 412-383-3463 · kaynarm@upmc.eduAmy Monroe, MPH, MBA · Study contact · 4126236382 · monroeal@upmc.eduMore trials in Pittsburgh